Medical Market Access

Pharmaceutical, biotechnology and medical device companies around the globe trust Optum™ to help them address the complex product development and commercialisation challenges they face.

With leading expertise in health economics and outcomes research and economic modelling, we develop and implement strategic study designs and health technology assessments that combine scientific and commercial objectives to help maximise the opportunities for your products in the marketplace.

Develop Comprehensive, Flexible Strategies for Enduring Success

Market access and reimbursement

At Optum, our Market Access and Reimbursement Group is focused on providing clients with the comprehensive research and strategy development needed to address payer, government and health technology assessment (HTA) agency requirements for payer coverage and reimbursement. With expertise in dossier preparation (including PBAC, MSAC, RPRC, PHARMAC), meta-analyses, indirect comparisons, health policy assessments, clinical practice guideline development and strategic plan development, we provide the insight and strategies that can help you successfully demonstrate the value of your products to all stakeholders in order to maximise your marketplace opportunities.


The Optum team has an outstanding track record in the development of economic models to support pricing, reimbursement and market access. We can develop global models with the flexibility to accommodate epidemiologic and health care data across multiple geographies. This lets a single model platform serve multiple regions. User-friendly interfaces can overlay complex model engines to simplify use in medical marketing, physician medical education or sales force activities.

  • Health economics
    and outcomes research

    • Delivering the scientific results to help realise your brand’s full potential • Proven expertise and scientific results to realise your brand’s full potential • Demonstrate the full value of your product and maximise market potential. • Proven expertise to guide your product research and launch strategy

  • Economic modelling

    • Providing robust, highly versatile model development to support your goals • Clinical, economic and quality-of-life data that better shapes your market decisions • Offering innovative tools to communicate your products more effectively • Proven expertise spanning all methodological approaches and therapeutic areas

  • Patient-reported Outcomes

Resource Centre

Solving the rare disease funding dilemma
It may be time to balance funding of rare disease therapies against financial sustainability — in a manner that reflects how Australians value equity in health care.
Managing future expenditure on new medicines
Given the rising costs of medicines and increased life expectancy, it may be time for Australia to consider a budget cap for new medicines.
Global Health Economics and Outcomes Research
Maximize the opportunities for your products in the marketplace.
Creating a sustainable PBS
As the costs of drugs continue to grow, so too do the options for reforming the PBS.
Connecting for better health

How do we ensure that health information available via the Internet is useful and credible to consumers?

Contact Us

Leaders & Experts

    We’re ready to put our solutions to work for you. Let’s start the conversation.
    Contact Us +61 2 9572 4500

    Please complete the short form below to help guide our discussion.

    * required

    Optum respects your privacy, view our Privacy Policy.


    Thank you for contacting us

    An Optum professional will contact you within one business day. If you have additional questions, please contact us at